Medical News

Trastuzumab Emtansine (T-DM1) in Patients with HER2-positive...
Ann. Oncol.

This exploratory analysis of patients with HER2-positive metastatic breast cancer and BM enrolled in a prospective...

24 Sep 2020

Prognostic Factors for Breast Cancer Patients with T1–2 Tumo...
Breast Cancer

Tumor size, ER/PR status, preoperative NLR and NMR were independent predictors of risk of recurrence. PMRT could...

21 Sep 2020

Long-term all-cause Mortality and its Association with Cardi...
BMC Cancer

This large cohort study showed higher all-cause mortality with a higher prevalence of hypertension, dyslipidemia,...

18 Sep 2020

Nomogram for Predicting the Overall Survival and Cancer-spec...
BMC Cancer

Age, sex, tumor size, grade, M stage, and surgery status were confirmed as independent prognostic variables for...

17 Sep 2020

eCMEs

Date: 26th September 2020
Time: 04:00 pm to 06:30 pm

Our Publications

Pomalong (Pomalidomide) Monograph

Pomalidomide-dexamethasone is a standard of care in patients with relapsed/refractory multiple myeloma following exhaustion of treatment options.

Q & A on Imatinib- Focused on CML

Imatinib, a tyrosine kinase inhibitor, induces durable responses in the majority of CML patients and is currently the standard of care for CML. This...

Q & A on Imatinib- Focused on GIST

Imatinib,a tyrosine kinase inhibitor, has been demonstrated to be effective in the treatment of unresectable or metastatic GISTs by inhibition of...

Slide Library

Management of Advanced Prostate Cancer: Current Concepts

Prostate cancer has become a major public health burden worldwide and its incidence rates are increasing in India.  Hormonal therapy or androgen...

 
Email this page
Clinical Appraisal of Abiraterone acetate in Management of CRPC

Prostate cancer has become a major public health burden worldwide. Castration or hormonal therapy is the mainstay of treatment for the management of...

 
Email this page
HBV Reactivation in Patients Undergoing Chemotherapy

The risk of hepatitis B virus (HB) reactivation is high in patients receiving chemotherapy for solid or hematological malignancies which may lead to...

 
Email this page
Haematological Malignancies

Haematological malignancies are the types of cancer that affect blood, bone marrow and lymph nodes. This slide set includes types, risk factors,...

 
Email this page

Key Trials

ENSURE Trial: Erlotinib versus Gemcitabine/cisplatin as First-line Treatment in EGFR mutation-positive Non-small-cell Lung Cancer Patients

ENSURE was the first and largest trial to prospectively investigate erlotinib versus chemotherapy in a broad Asian population. The study showed that...

Efficacy and Safety of Intravesical Bacillus Calmette-Guérin Immunotherapy in Patients with Non-Muscle-Invasive Bladder Cancer Presenting with Asymptomatic Bacteriuria (ABU)

This study provides you a brief insight on the efficacy and safety of intravesical BCG instillations when used in patients with Non-Muscle-Invasive...

Non-Inferiority of Degarelix with Goserelin in Chinese Men with Prostate Cancer

Degarelix was non-inferior to goserelin in achieving and maintaining testosterone suppression at castrate levels with an acceptable safety profile...

EURTAC Trial: Erlotinib versus Standard Chemotherapy as First-line Treatment in Advanced EGFR mutation-positive NSCLC Patients

EURTAC is the first prospective head to- head phase 3 study comparing the efficacy and safety of first-line erlotinib with platinum-based...

Patient Education

All You Wanted to Know About Thyroid Cancer

Thyroid cancer is relatively uncommon compared to other cancers. This input describes the risk factors, symptoms, diagnosis and over all treatment fo...

All You Wanted to Know about Prostate Cancer

Prostate is one of the most common cancers in men. This material describes risk factors, symptoms, diagnosis and treatment of prostate cancer. Also,...

Living with Leukemia/Lymphoma

Tips for patient with leukaemia and lymphoma are explained along with pictures for better understanding. 

All You Wanted to Know about Ovarian Cancer

Risk factors, signs & symptoms, factors known to reduce ovarian cancer, diagnosis, treatment options and how to reduce risk of ovarian cancer giv...

Poll

Your choice of drug in the first-line treatment of patients with metastatic colorectal cancer treatment (CRC)
Capecitabine
44% (4 votes)
Tegafur uracil
0% (0 votes)
5-FU
56% (5 votes)
Total votes: 9